Literatur
AAO Preferred Practice Pattern: „Comprehensive Adult Medical Eye Evaluation“, „Age Related Macular Degeneration“, http://www.aao.org/ aao/education/library/ppp/?prod=Preferred%20Practice%20Pattern
Verteporfin Roundtable 2000 and 2001 Participants (2002) Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group principal investigators; Verteporfin in photodynamic therapy (VIP) study group principal investigators: Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 22(1): 6–18
Verteporfin Roundtable Participants (2005) Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 25(2): 119–34
BVA und DOG-Leitlinie Nr. 4: Augenärztliche Basisdiagnostik bei Patienten ab dem 7. Lebensjahr. http://www.augeninfo.de/leit/leit04.htm
BVA und DOG-Leitlinie Nr. 21: Altersabhängige Makuladegeneration. http://www.augeninfo.de/leit/leit21.htm
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stur, M. Stellungnahme 2006 der Netzhautkommission der ÖOG zur AMD-Diagnostik. Spektrum Augenheilkd 20, 167–168 (2006). https://doi.org/10.1007/BF03163509
Issue Date:
DOI: https://doi.org/10.1007/BF03163509